Geraldine A. Henwood Ph.D.
Chief Executive Officer and Director,Garnet Biotherapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 24 board members in 4 different organizations across 8 different industries.|
See Board Relationships
Dr. Geraldine A. Henwood, also known as Gerri, Ph.D., has been the Chief Development Officer of Iomab-B at Actinium Pharmaceuticals, Inc. since September 2012. Dr. Henwood has been the Chief Executive Officer of Garnet Biotherapeutics, Inc. since November 2008. She has been the Chief Executive Officer and President of RECRO Pharma, Inc. since November 15, 2007. She is a Venture Partner at SCP Vitalife. She is the Founder of Malvern Consulting Group and served as its ...
490 Lapp RoadPhone: 484-395-2440
Malvern, Pennsylvania 19355
Board Members Memberships*
Chief Executive Officer, President and Director
Chief Executive Officer and Director
Director and Member of Compensation Committee
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.